The Journal of Antibiotics · 1996 · 52 citations · 19 references
Life SciencesMedicinal ChemistryPharmacologyDrug DiscoveryMolecular VirologyVirologyAntiretroviral TherapyAntiviral AgentsAntiviral PharmacologyEnzyme InhibitionPeptide ChemistryAntiviral Drug MechanismsAntiviral PeptidesBiological Activity FeaturesNucleoside Reverse Transcriptase InhibitorsSubstituent Effects On Biological ActivityViral Polymerase Inhibitors
Quinoxapeptin A and B are novel chromodepsipeptides which were isolated from a nocardioform actinomycete with indeterminant morphology. Quinoxapeptins A and B are potent inhibitors of HIV-1 and HIV-2 reverse transcriptase and almost equally active against two single mutants forms as well as a double mutant form of HIV-1 reverse transcriptase. Quinoxapeptin A and B are specific inhibitors of HIV-1 and HIV-2 reverse transcriptase because they did not inhibit human DNA polymerase alpha, beta, gamma and delta. Quinoxapeptin A and B are structurally similar to luzopeptin A which was also active against HIV-1 and HIV-2 reverse transcriptase.
19
Classification and Regression Trees.
Alexander Gordon, Leo Breiman, Jerome H. Friedman et al. · Biometrics · 1984 · 23.9K citations
Classification and Regression Trees.
John Van Ryzin, Leo Breiman, Jerome H. Friedman et al. · Journal of the American Statistical Association · 1986 · 21K citations